THE TGA has advised that GlaxoSmithKline (GSK) has issued a product correction for certain batches of their Flixotide and Pavtide Accuhalers, as a small number of them may not load the next dose automatically.
Devices from the affected batches will function normally at first, and may then stop working, requiring a manual reset.
This entails pushing the lever down towards the mouthpiece, then pushing it up away from the mouthpiece to 'load' the dose, as per normal instructions - the counter will indicate it has been reset correctly.
If the dose is not manually reset, this may lead to a short-term flare-up of asthma symptoms.
Patients are advised to keep using the devices, and ask their doctor or pharmacist for help if needed - learn more HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 16 Apr 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Apr 26
